Li et al.24 demonstrated that HCC patients with intrahepatic metastasis and macrovascular invasion have higher serum ANGPTL4 levels than those without these features, suggesting a possible role of ANGPTL4 in HCC progression. This evidence concerns the gene ANGPTL4 and hepatocellular carcinoma.